EP0648268A4 - Fragments therapeutiques du facteur willebrand. - Google Patents
Fragments therapeutiques du facteur willebrand.Info
- Publication number
- EP0648268A4 EP0648268A4 EP19920909515 EP92909515A EP0648268A4 EP 0648268 A4 EP0648268 A4 EP 0648268A4 EP 19920909515 EP19920909515 EP 19920909515 EP 92909515 A EP92909515 A EP 92909515A EP 0648268 A4 EP0648268 A4 EP 0648268A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- von willebrand
- willebrand factor
- therapeutic fragments
- fragments
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67552991A | 1991-03-27 | 1991-03-27 | |
| PCT/US1992/002475 WO1992017192A1 (fr) | 1991-03-27 | 1992-03-27 | Fragments therapeutiques du facteur willebrand |
| US675529 | 1996-07-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0648268A4 true EP0648268A4 (fr) | 1994-04-20 |
| EP0648268A1 EP0648268A1 (fr) | 1995-04-19 |
Family
ID=24710889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP92909515A Withdrawn EP0648268A1 (fr) | 1991-03-27 | 1992-03-27 | Fragments therapeutiques du facteur willebrand |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0648268A1 (fr) |
| AU (1) | AU1757592A (fr) |
| CA (1) | CA2107100A1 (fr) |
| WO (1) | WO1992017192A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5847086A (en) * | 1991-06-20 | 1998-12-08 | Centeon L.L.C. | Therapeutic fragments of von Willebrand factor |
| FR2686901A1 (fr) * | 1992-01-31 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant. |
| US6197526B1 (en) * | 1999-01-04 | 2001-03-06 | Dyax Corp. | Polypeptides for binding human factor VIII and fragments of human factor VIII |
| US7112438B2 (en) | 1999-01-04 | 2006-09-26 | Dyax Corp. | Binding molecules for human factor VIII and factor VIII-like proteins |
| FI20010492A0 (fi) * | 2001-03-12 | 2001-03-12 | Licentia Oy | Uuden von Willebrandin tekijän A3-domeenissa sijaitsevan funktionaalisen sitomiskohdan identifiointi verihiutaleintegriini alfaIIbbeta3 :a varten |
| CN110624105B (zh) * | 2019-09-24 | 2021-06-11 | 苏州大学 | 血管性血友病因子的结构敏感多肽抗原的序列 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000357A1 (fr) * | 1991-06-28 | 1993-01-07 | Rhone-Poulenc Rorer International (Holdings) Inc. | Polypeptides therapeutiques bases sur le facteur de von villebrand |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
-
1992
- 1992-03-27 AU AU17575/92A patent/AU1757592A/en not_active Abandoned
- 1992-03-27 WO PCT/US1992/002475 patent/WO1992017192A1/fr not_active Ceased
- 1992-03-27 EP EP92909515A patent/EP0648268A1/fr not_active Withdrawn
- 1992-03-27 CA CA 2107100 patent/CA2107100A1/fr not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000357A1 (fr) * | 1991-06-28 | 1993-01-07 | Rhone-Poulenc Rorer International (Holdings) Inc. | Polypeptides therapeutiques bases sur le facteur de von villebrand |
Non-Patent Citations (3)
| Title |
|---|
| FILE SERVER STN KARLSRUHE,FILE MEDLINE ABSTRACT NO.91185601 & J CLIN INVEST, (1991 APR) 87(4) 1220-6 * |
| FILE SERVER STN KARLSRUHE,FILE MEDLINE ABSTRACT NO.91187908 & PROC NATL ACAD SCI USA, (1991 APR 1) 88(7) 2946-50 * |
| See also references of WO9217192A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992017192A1 (fr) | 1992-10-15 |
| AU1757592A (en) | 1992-11-02 |
| CA2107100A1 (fr) | 1992-09-28 |
| EP0648268A1 (fr) | 1995-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9127150D0 (en) | Novel treatment | |
| GB9215633D0 (en) | Novel treatment | |
| GB9226860D0 (en) | Novel treatment | |
| GB9211148D0 (en) | Novel treatment | |
| GB8619725D0 (en) | Homogenous interferon fragments | |
| GB9225860D0 (en) | Novel treatment | |
| AU2297792A (en) | Therapeutic polypeptides based on von willebrand factor | |
| EP0648268A4 (fr) | Fragments therapeutiques du facteur willebrand. | |
| GB9226957D0 (en) | Novel treatment | |
| GB9203535D0 (en) | Novel treatment iii | |
| AU9069591A (en) | Therapeutic fragments of von willebrand factor | |
| AP9300527A0 (en) | Novel treatment | |
| GB9203637D0 (en) | Novel treatment | |
| GB9225859D0 (en) | Novel treatment | |
| GB8816505D0 (en) | Novel treatment | |
| GB9105560D0 (en) | Novel treatment i | |
| GB8820102D0 (en) | Novel treatment | |
| GB8802254D0 (en) | Novel treatment | |
| GB8819577D0 (en) | Novel treatment | |
| GB8826569D0 (en) | Novel treatment | |
| GB8828780D0 (en) | Novel treatment | |
| IE880120L (en) | Novel treatment | |
| GB8819576D0 (en) | Novel treatment | |
| GB9103850D0 (en) | Novel treatment iii | |
| GB9112720D0 (en) | Novel treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19931027 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19941001 |
|
| RHK1 | Main classification (correction) |
Ipc: C12N 15/12 |